Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
15.00
-0.59 (-3.78%)
Sep 23, 2025, 1:09 PM EDT - Market open
Immunovant Market Cap
Immunovant has a market cap or net worth of $2.61 billion as of September 23, 2025. Its market cap has decreased by -46.86% in one year.
Market Cap
2.61B
Enterprise Value
2.12B
1-Year Change
-46.86%
Ranking
Category
Stock Price
$15.00
Market Cap Chart
Since June 21, 2019, Immunovant's market cap has increased from $124.38M to $2.61B, an increase of 2,002.31%. That is a compound annual growth rate of 62.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2025 | 2.72B | -25.26% |
| Dec 31, 2024 | 3.64B | -40.34% |
| Dec 29, 2023 | 6.09B | 165.79% |
| Dec 30, 2022 | 2.29B | 134.03% |
| Dec 31, 2021 | 979.80M | -78.33% |
| Dec 31, 2020 | 4.52B | 404.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.75B |
| Johnson & Johnson | 419.56B |
| AbbVie | 393.22B |
| UnitedHealth Group | 309.11B |
| Novo Nordisk | 268.59B |
| AstraZeneca | 240.79B |
| Novartis AG | 239.81B |
| Abbott Laboratories | 237.78B |